Welch’s drug pricing bill passes Senate by Q4 2028
user-generated· regulatory
Welch’s drug pricing bill passes Senate by Q4 2028
Market overview
Given bipartisan momentum on drug pricing and Trump’s signaled support, the bill is likely to gain sufficient Senate votes despite partisan resistance. Passage requires 60 votes under current filibuster rules.
regulatory prediction market
- Implied probability (Yes)
- 70%
- Closes
- 2028-12-31
Source: user-generated
More regulatory markets
- G7 nations approve $2B mpox vaccine funding by Q2 2027 — 60% Yes
- UK NHS to announce expanded prostate screening by 2027 — 72% Yes
- Baby care proceedings in England to decrease by 2028 — 60% Yes
- UK government introduces mandatory salt labeling for restaurant menus by 2028 — 80% Yes
- Federal crime data integrity bill passes Congress by November 2026 — 63% Yes
- DOJ opens criminal probe into AI hacks by Mar 31 — 40% Yes
- OpenAI delays IPO to Q3 2027 amid regulatory scrutiny — 80% Yes
- Platner will outspend Collins in national ad buys by Q4 2026 — 68% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…